Supriya Lifescience P/B Ratio

Current P/B Ratio
6.17
High Valuation
Very High - Significant premium, high growth expectations or speculative

Supriya Lifescience (SUPRIYA) P/B ratio is 6.17 (High), book value per share ₹748.75 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read SUPRIYA dividend track record for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/B Ratio 6.17
Current Price ₹906.30
Book Value/Share ₹748.75
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹1,198 Cr
Share Capital ₹16 Cr
Reserves & Surplus ₹1,182 Cr
Outstanding Shares 16,000,000
Book Value per Share ₹748.75

Valuation Signal

Signal Overvalued
Historical Avg 1.04
Historical Range 0.61 - 1.45
Percentile 100.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

SUPRIYA P/B Ratio — Valuation Insights & Book Value Analysis

Supriya Lifescience price-to-book ratio interpretation, valuation status and historical context — current P/B 6.17 (High). For live price, earnings yield and the full fundamental profile, see SUPRIYA share price.

  • Stock appears overvalued with PB of 6.17, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 493.3% above historical average
  • Trading at premium to sector average PB of -0.01

Supriya Lifescience P/B Ratio Historical Trend

SUPRIYA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore SUPRIYA value investing to estimate fundamental worth using multiple valuation models.

SUPRIYA Historical P/B Ratio — Book Value Per Share & Year-End Price

Supriya Lifescience annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 1.21 ₹748.75 ₹906.30 ₹1,198 Moderate
2025 1.21 ₹623.12 ₹751.50 ₹997 Moderate
2024 1.45 ₹509.38 ₹739.80 ₹815 Moderate
2023 0.72 ₹437.5 ₹314.75 ₹700 Low
2022 0.61 ₹385.0 ₹235.05 ₹616 Low

SUPRIYA vs Healthcare Peers — P/B Ratio Comparison

Supriya Lifescience P/B 6.17 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low